期刊文献+

外周血suPAR在恶性血液病化疗后中性粒细胞缺乏伴发热患者中的意义 被引量:4

The clinical value of soluble urokinase plasminogen activa- tion receptor in febrile neutropenic patients with hemato- logical malignancies after chemotherapy
原文传递
导出
摘要 恶性血液病化疗后粒细胞缺乏(粒缺)伴感染是导致患者死亡的主要原因之一。粒缺伴感染表现多样且进展迅速,传统炎性标志物C反应蛋白(CRP)的特异性不高,血清降钙素原(PCT)虽然是目前较为经典的标志物,但其在粒缺患者发热72h后才逐渐升高。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2017年第12期1066-1068,共3页 Chinese Journal of Hematology
基金 基金项目:天津市卫生局科技基金攻关项目(15KG135) 天津市科委青年基金(15JCQNJC45500)
  • 相关文献

二级参考文献18

  • 1汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 2FreifeldAG, BowEJ, SepkowitzKA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2011, 52(4):427-431. doi: 10.1093/cid/ciq147.
  • 3AverbuchD, OraschC, CordonnierC, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia [J]. Haematologica, 2013, 98(12):1826-1835. doi: 10.3324/haematol.2013.091025.
  • 4AverbuchD, CordonnierC, LivermoreDM, et al. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)[J]. Haematologica, 2013, 98(12):1836-1847. doi: 10.3324/haematol.2013.091330.
  • 5ZhaiW, ZhangX, WeiJ, et al. A Prospective Observational Study of Antibiotic Therapy in Febrile Neutropenia Patients with Hematological Malignances from Multiple centers in Northeast China [J]. Int J Infect Dis, 2015, 37:97-103. doi: 10.1016/j.ijid.2015.04.015.
  • 6KernWV, MarchettiO, DrgonaL, et al. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV [J]. J Clin Oncol, 2013, 31(9):1149-1156. doi: 10.1200/JCO.2012.45.8109.
  • 7WunderinkRG, RelloJ, CammarataSK, et al. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia[J]. Chest, 2003, 124(5):1789-1797.
  • 8ChaftariAM, HachemR, MulanovichV, et al. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients [J]. Int J Antimicrob Agents, 2010, 36(2):182-186. doi: 10.1016/j.ijantimicag.2010.03.015.
  • 9Gafter-GviliA, FraserA, PaulM, et al. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy [J]. Cochrane Database Syst Rev, 2012, 1:CD004386. doi: 10.1002/14651858.CD004386.pub3.
  • 10RazonableRR, LitzowMR, KhaliqY, et al. Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis [J]. Clin Infect Dis, 2002, 34(11):1469-1474. doi: 10.1086/340352.

共引文献238

同被引文献49

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部